Salt Lake City-based Nimbus Concepts, a medtech company that markets devices for pain management, has a new CEO. The managing partners of Med Venture Holdings, the medical industry investment firm that owns Nibus, has named Bret Boudousquie to lead the company.
Boudousquie’s appointment was effective in July. In his new role, he will oversee the U.S. commercialization, global expansion and ongoing development of the Nimbus product line and its future products, said Travis Sessions, a partner at Med Venture Holdings.
Boudousquie comes to Nimbus from RadiaDyne, where he was president. RadiaDyne is a commercial-stage company that develops and markets medical devices and patient monitoring equipment used during radiotherapy for cancer treatment. Prior to RadiaDyne, Boudousquie’s career was focused on evolving minimally invasive surgical procedures primarily in orthopedics, spine and general surgery.
“I am very excited to work with the Nimbus team and look forward to replicating the great success they have had in Australia, as we expand in the U.S. and other countries throughout the world,” Boudousquie said. “We have great confidence in the Nimbus RF Multitined Expandable Electrode as both current users and new users have shared the great value Nimbus provides for their chronic pain patients.”
“Nimbus is providing great value to our interventional pain management physicians, hospital customers and patient stakeholders,” said Sessions. “We have confidence that under Bret’s leadership, we can leverage this experience and capture the significant market opportunity in the U.S. and other countries. I am confident that Bret’s leadership and track record of driving growth with differentiated medical technologies will ensure the success of this business.”